History
  • No items yet
midpage
778 F. Supp. 2d 667
E.D. Va.
2011
Read the full case

Background

  • Gore sued Medtronic for patent infringement of the '870 patent (Intraluminal Stent Graft) in the Eastern District of Virginia.
  • The '870 patent owners/licensees: Gore Enterprise Holdings owns the patent; Gore & Associates licenses rights to practice in the United States.
  • The August 28, 2009 Settlement and License Agreement includes a forum for patent disputes in this court and waivers of jury trial, injunctions, exemplary damages, and attorneys' fees for such disputes.
  • Plaintiffs allege direct and indirect infringement by Medtronic of the '870 patent, with claims that Medtronic's Talent abdominal and thoracic stent grafts infringe.
  • Defendants moved to dismiss (Nov. 19, 2010) arguing (i) improper reliance on the Agreement for jurisdiction and (ii) failure to plead under Twombly/Iqbal.
  • The court denied dismissal on personal jurisdiction and direct infringement, granted leave to amend for indirect infringement, and allowed clarifications consistent with Form 18.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether forum selection clause establishes personal jurisdiction Gore contends the clause consents to jurisdiction in ED Va. Medtronic argues clause does not bind personal jurisdiction in this court. Clause valid; ED Va has personal jurisdiction.
Whether the complaint adheres to the Form 18 pleading standard after Twombly/Iqbal Complaint tracks Form 18 and alleges direct infringement sufficiently. Form 18 is outdated post-Twombly/Iqbal and requires more detailed pleading. Complaint sufficiently tracks Form 18 to survive Rule 12(b)(6).
Whether the complaint properly alleges direct infringement against multiple Medtronic entities Gore asserts all three Medtronic entities directly infringe. Should specify which entity infringes; otherwise insufficient notice. Court construes as direct infringement by each defendant; no amendment required.
Whether the complaint may include indirect infringement claims or must be amended first Were indirect infringement still alleged; no immediate amendment necessary. Indirect infringement should be addressed separately; may defeat claims. Plaintiffs granted leave to amend to remove indirect infringement; such issues moot upon amendment.
Whether the damages relief sought is barred by the Agreement Damages sought are within what the Agreement allows to be pursued. Agreement precludes certain enhanced damages and injunctive relief. Damages claim not dismissed; potential limits may exist, but not ground for 12(b)(6) dismissal.

Key Cases Cited

  • Avocent Huntsville Corp. v. Aten Int'l Co., 552 F.3d 1324 (Fed. Cir. 2008) (Federal Circuit governs patent jurisdiction questions)
  • Monsanto Co. v. McFarling, 302 F.3d 1291 (Fed. Cir. 2002) (forum selection clauses can confer jurisdiction when valid)
  • Patent Rights Prot. Grp., LLC v. Video Gaming Techs., Inc., 603 F.3d 1364 (Fed. Cir. 2010) (applies Federal Circuit law to personal jurisdiction in patent cases)
  • TruServ Corp. v. Flegles, Inc., 419 F.3d 584 (7th Cir. 2005) (forum-selection clause can confer personal jurisdiction)
  • McZeal v. Sprint Nextel Corp., 501 F.3d 1354 (Fed. Cir. 2007) (Form 18 can suffice to state a direct infringement claim)
  • Cal. Inst. of Computer Assisted Surgery v. Med-Surgical Servs., Inc., 2010 WL 3063132 (N.D. Cal. 2010) (notice considerations in patent actions; damages timing)
  • Colida v. Nokia, Inc., 347 Fed.Appx. 568 (Fed. Cir. 2009) (design patents and Form 18 context; not binding precedent here)
  • McZeal v. Sprint Nextel Corp., 501 F.3d 1354 (Fed. Cir. 2007) (Form 18 sufficiency for notice pleading)
Read the full case

Case Details

Case Name: W.L. Gore & Associates, Inc. v. Medtronic, Inc.
Court Name: District Court, E.D. Virginia
Date Published: Apr 20, 2011
Citations: 778 F. Supp. 2d 667; 2011 WL 1541312; 2011 U.S. Dist. LEXIS 44941; Civil Action 2:10cv441
Docket Number: Civil Action 2:10cv441
Court Abbreviation: E.D. Va.
Log In
    W.L. Gore & Associates, Inc. v. Medtronic, Inc., 778 F. Supp. 2d 667